Clinical trials query results
From Health Canada
- Medical condition:
- OBSESSIVE COMPULSIVE DISORDER,POST-TRAUMATIC STRESS DISORDER,MAJOR DEPRESSIVE DISORDER,ANXIETY DISORDER,BIPOLAR DISORDER
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN
- Protocol title:
- PSILOCYBIN ASSISTED THERAPY FOR ANXIETY AND MOOD DISORDERS: A TRANSDIAGNOSTIC OPEN LABEL CLINICAL TRIAL FOR IMPROVING WELL-BEING (PAM-WELL)
- Sponsor name:
- BRAIN AND COGNITION DISCOVERY FOUNDATION
- Date of no objection letter:
- 2022-08-03
- Control number:
- 265581
- Trial status:
- ONGOING
- Date study started:
- 2022-09-23